The antiatherogenic effects of antihypertensive drugs: Experimental and clinical evidence

Alberto Zanchetti

Research output: Contribution to journalArticle

Abstract

The question whether some classes of antihypertensive drugs have an antiatherogenic action independent of the antihypertensive one has been investigated through a large series of experimental studies; on the other hand, clinical evidence is still rather scanty. Most experimental investigations have shown a significant antiatherogenic action of the antihypertensive compounds, but only when the drug is administered simultaneously with the atherogenic stimulus (mostly cholesterol feeding). When the drug is administered weeks or months after the beginning of atherosclerosis (as in the Watanabe heritable hyperlipemic rabbit), no antiatherogenic effect has been shown, with a single exception. Although the most numerous data available are on calcium antagonists, almost all antihypertensive classes tested have shown some favorable effect on some experimental model. The few clinical studies completed so far are on coronary patients; they have provided arteriographic evidence that various calcium-antagonists have little effect on well-developed lesions and display a beneficial action on new or early lesions only. Ultrasound studies are now underway to compare the effects of calcium-antagonists and diuretics on asymptomatic carotid atherosclerotic lesions in hypertensive patients.

Original languageEnglish
Pages (from-to)307-331
Number of pages25
JournalClinical and Experimental Hypertension
VolumeA14
Issue number1-2
DOIs
Publication statusPublished - 1992

Fingerprint

Antihypertensive Agents
Calcium
Diuretics
Pharmaceutical Preparations
Atherosclerosis
Theoretical Models
Cholesterol
Rabbits

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology

Cite this

The antiatherogenic effects of antihypertensive drugs : Experimental and clinical evidence. / Zanchetti, Alberto.

In: Clinical and Experimental Hypertension, Vol. A14, No. 1-2, 1992, p. 307-331.

Research output: Contribution to journalArticle

@article{7e25e628f33d4778a3d911eb4a0d178f,
title = "The antiatherogenic effects of antihypertensive drugs: Experimental and clinical evidence",
abstract = "The question whether some classes of antihypertensive drugs have an antiatherogenic action independent of the antihypertensive one has been investigated through a large series of experimental studies; on the other hand, clinical evidence is still rather scanty. Most experimental investigations have shown a significant antiatherogenic action of the antihypertensive compounds, but only when the drug is administered simultaneously with the atherogenic stimulus (mostly cholesterol feeding). When the drug is administered weeks or months after the beginning of atherosclerosis (as in the Watanabe heritable hyperlipemic rabbit), no antiatherogenic effect has been shown, with a single exception. Although the most numerous data available are on calcium antagonists, almost all antihypertensive classes tested have shown some favorable effect on some experimental model. The few clinical studies completed so far are on coronary patients; they have provided arteriographic evidence that various calcium-antagonists have little effect on well-developed lesions and display a beneficial action on new or early lesions only. Ultrasound studies are now underway to compare the effects of calcium-antagonists and diuretics on asymptomatic carotid atherosclerotic lesions in hypertensive patients.",
author = "Alberto Zanchetti",
year = "1992",
doi = "10.3109/10641969209036190",
language = "English",
volume = "A14",
pages = "307--331",
journal = "Clinical and Experimental Hypertension",
issn = "1064-1963",
publisher = "Informa Healthcare",
number = "1-2",

}

TY - JOUR

T1 - The antiatherogenic effects of antihypertensive drugs

T2 - Experimental and clinical evidence

AU - Zanchetti, Alberto

PY - 1992

Y1 - 1992

N2 - The question whether some classes of antihypertensive drugs have an antiatherogenic action independent of the antihypertensive one has been investigated through a large series of experimental studies; on the other hand, clinical evidence is still rather scanty. Most experimental investigations have shown a significant antiatherogenic action of the antihypertensive compounds, but only when the drug is administered simultaneously with the atherogenic stimulus (mostly cholesterol feeding). When the drug is administered weeks or months after the beginning of atherosclerosis (as in the Watanabe heritable hyperlipemic rabbit), no antiatherogenic effect has been shown, with a single exception. Although the most numerous data available are on calcium antagonists, almost all antihypertensive classes tested have shown some favorable effect on some experimental model. The few clinical studies completed so far are on coronary patients; they have provided arteriographic evidence that various calcium-antagonists have little effect on well-developed lesions and display a beneficial action on new or early lesions only. Ultrasound studies are now underway to compare the effects of calcium-antagonists and diuretics on asymptomatic carotid atherosclerotic lesions in hypertensive patients.

AB - The question whether some classes of antihypertensive drugs have an antiatherogenic action independent of the antihypertensive one has been investigated through a large series of experimental studies; on the other hand, clinical evidence is still rather scanty. Most experimental investigations have shown a significant antiatherogenic action of the antihypertensive compounds, but only when the drug is administered simultaneously with the atherogenic stimulus (mostly cholesterol feeding). When the drug is administered weeks or months after the beginning of atherosclerosis (as in the Watanabe heritable hyperlipemic rabbit), no antiatherogenic effect has been shown, with a single exception. Although the most numerous data available are on calcium antagonists, almost all antihypertensive classes tested have shown some favorable effect on some experimental model. The few clinical studies completed so far are on coronary patients; they have provided arteriographic evidence that various calcium-antagonists have little effect on well-developed lesions and display a beneficial action on new or early lesions only. Ultrasound studies are now underway to compare the effects of calcium-antagonists and diuretics on asymptomatic carotid atherosclerotic lesions in hypertensive patients.

UR - http://www.scopus.com/inward/record.url?scp=0026599514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026599514&partnerID=8YFLogxK

U2 - 10.3109/10641969209036190

DO - 10.3109/10641969209036190

M3 - Article

C2 - 1541043

AN - SCOPUS:0026599514

VL - A14

SP - 307

EP - 331

JO - Clinical and Experimental Hypertension

JF - Clinical and Experimental Hypertension

SN - 1064-1963

IS - 1-2

ER -